Acquisition
Acquire specialized outpatient practices with durable clinical demand.
We focus on founder and physician-led businesses where better systems can compound high-quality care into regional platforms.
Sequence Capital partners with healthcare founders, clinicians, and investors to build tech-enabled outpatient platforms where better operations improve access, provider capacity, and patient outcomes.
Access + Capacity
27.4%
No-show risk
Predictive recall triggered across 4 clinics.
PHI-safe layer
Auditable workflow routing for clinical data systems.
Clinical throughput model
AI-native
Target settings
Outpatient
Platform motion
Buy + build
Acquisition
We focus on founder and physician-led businesses where better systems can compound high-quality care into regional platforms.
Acceleration
Our model pairs institutional capital with workflow automation, revenue-cycle intelligence, and data-informed growth planning.
Intake triage, smart scheduling, eligibility checks, and no-show prevention that reduce administrative drag.
Documentation support, coding QA, and outcome tracking designed around specialty-specific provider workflows.
Shared operating systems, referral visibility, and clinical playbooks across independent practice nodes.
We favor specialties with recurring demand, fragmented local markets, and clear technology-adoption gaps.
High-frequency care models with strong continuity, measurable outcomes, and meaningful access constraints.
Developmental care networks where demand outpaces supply and family engagement shapes longitudinal outcomes.
Specialized practices with ancillary service complexity and significant workflow standardization opportunity.
Medical dermatology and pathology-adjacent workflows where coding quality and access drive performance.
The matrix prioritizes reimbursement stability, fragmentation, patient access constraints, and the practical ability to introduce better operating systems.
Our process is intentionally sequenced: diagnose the system, automate repeatable work, improve patient continuity, then expand with data.
Phase 01
Map clinical operations, referral flows, payer dynamics, and data readiness before changing the operating model.
Phase 02
Deploy targeted automation for repeatable administrative work while keeping clinical review where it belongs.
Phase 03
Build digital entry points, follow-up loops, and recall systems that improve access and continuity of care.
Phase 04
Use market, capacity, and outcomes data to prioritize de novos, acquisitions, and specialty expansion.
99.9%
Target uptime
HIPAA
Design lens
Clean operational data model for performance and clinical activity.
AI workflow layer for repeatable, auditable administrative tasks.
Privacy-first controls for PHI-aware analysis and process design.
Shared reporting layer for operators, clinicians, and investors.
We support healthcare private equity teams with technical due diligence, AI-readiness assessment, and portfolio value creation planning across specialty care assets.
Technical debt and scalability review
HIPAA and clinical data security assessment
AI authenticity and automation-readiness audit
Value creation roadmap for the first 180 days
Typical output
A clear diligence readout plus a pragmatic 180-day AI implementation roadmap.
Share a healthcare services opportunity, technical diligence need, or portfolio support question. We will route the inquiry to the right Sequence Capital partner.
Direct Channel
team@sequence-cap.com